Unethical studies on Chinese minority groups are being retracted — but not fast enough, critics say
By Dyani Lewis,
Nature
| 01. 24. 2024
Yves Moreau thought something was amiss when he came across a genetics paper about Tibetans in China. In the 2022 report in PLoS ONE, a team of researchers had collected blood samples from hundreds of people in the Tibet Autonomous Region of China and recorded genetic markers on their X chromosomes. The researchers concluded that this analysis was useful for forensic identification and paternity testing1.
The paper raised immediate red flags for Moreau. Over the past half-decade Moreau, who is a computational geneticist at the Catholic University of Leuven in Belgium, has become deeply concerned about the ethics of studies that report the collection of biometric data from vulnerable or oppressed groups of people2.
n this case, he worried that Chinese security forces might have been involved in the work. One concern was that the blood was collected by being blotted onto reference cards — a method of choice for police forces. Moreover, in 2022, the international advocacy organization Human Rights Watch, among others, had reported that a mass DNA-collection programme of Tibetan populations was...
Related Articles
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
By Julia Black, MIT Technology Review | 10.16.2025
Consider, if you will, the translucent blob in the eye of a microscope: a human blastocyst, the biological specimen that emerges just five days or so after a fateful encounter between egg and sperm. This bundle of cells, about the size of...